Co-Authored-By: Claude Opus 4.8 <noreply@anthropic.com>
7.1 KiB
type, title, description, jurisdiction, legislature, session, identifier, citation, classification, subjects, status, primary_sponsors, version_count, action_count, vote_count, first_action, last_action, source, source_identifier, source_url, source_hash, vintage, source_snapshot, retrieved_at, confidence, tags
| type | title | description | jurisdiction | legislature | session | identifier | citation | classification | subjects | status | primary_sponsors | version_count | action_count | vote_count | first_action | last_action | source | source_identifier | source_url | source_hash | vintage | source_snapshot | retrieved_at | confidence | tags | |||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Bill | Health insurance; if prior authorization request is approved for prescription drugs. | Health insurance; prior authorization. Requires that any provider contract between a carrier and a participating health care provider contain specific provisions that require that if a prior authorization request is approved for prescription drugs and such prescription drugs have been scheduled, provided, or delivered to the patient consistent with the authorization, the carrier shall not revoke, limit, condition, modify, or restrict that authorization unless (i) there is evidence that the authorization was obtained based on fraud or misrepresentation; (ii) final actions by the U.S. Food and Drug Administration, other regulatory agencies, or the manufacturer remove the drug from the market, limit its use in a manner that affects the authorization, or communicate a patient safety issue that would affect the authorization alone or in combination with other authorizations; (iii) a combination of drugs prescribed would cause a drug interaction; or (iv) a generic or biosimilar is added to the prescription drug formulary. The bill provides that such provisions do not require a carrier to cover any benefit not otherwise covered or cover a prescription drug if the enrollee is no longer covered by a health plan on the date the prescription drug was scheduled, provided, or delivered. This bill is identical to SB 98. | us/states/va | Virginia General Assembly | 2024 | HB 1134 | Virginia HB 1134 (2024) |
|
enacted |
|
4 | 30 | 6 | 2024-01-10 | 2024-04-02 | openstates | ocd-bill/896d19e8-cff5-49d7-8f95-960eac7cf95b | https://lis.virginia.gov/cgi-bin/legp604.exe?241+sum+HB1134 | edd445962066fc1402791c298843e7e9b1deddc9eab31e52c39a11295b6e27b1 | 2026-07-01 | https://data.openstates.org/daily/2026-07-01/public.pgdump | 2026-07-06 | reported |
|
Virginia HB 1134 (2024) — Health insurance; if prior authorization request is approved for prescription drugs.
Health insurance; prior authorization. Requires that any provider contract between a carrier and a participating health care provider contain specific provisions that require that if a prior authorization request is approved for prescription drugs and such prescription drugs have been scheduled, provided, or delivered to the patient consistent with the authorization, the carrier shall not revoke, limit, condition, modify, or restrict that authorization unless (i) there is evidence that the authorization was obtained based on fraud or misrepresentation; (ii) final actions by the U.S. Food and Drug Administration, other regulatory agencies, or the manufacturer remove the drug from the market, limit its use in a manner that affects the authorization, or communicate a patient safety issue that would affect the authorization alone or in combination with other authorizations; (iii) a combination of drugs prescribed would cause a drug interaction; or (iv) a generic or biosimilar is added to the prescription drug formulary. The bill provides that such provisions do not require a carrier to cover any benefit not otherwise covered or cover a prescription drug if the enrollee is no longer covered by a health plan on the date the prescription drug was scheduled, provided, or delivered. This bill is identical to SB 98.
Version chain
The bill's text revisions, in order — the diff chain from filing to enrollment.
- CHAP0320 (committee substitute) — source
- Committee substitute printed 24105981D-H1 (committee substitute) — source
- HB1134ER (committee substitute) — source
- Prefiled and ordered printed; offered 01/10/24 24101235D (committee substitute) — source
Votes
- Reported from Labor and Commerce with substitute (22-Y 0-N) — 22–0 (pass) · lower
- Reported from Commerce and Labor (15-Y 0-N) — 15–0 (pass) · upper
- Passed Senate (39-Y 0-N) — 39–0 (pass) · upper
- Subcommittee recommends reporting with substitute (7-Y 0-N) — 7–0 (pass) · lower
- VOTE: Block Vote Passage (99-Y 0-N) — 98–0 (pass) · lower
- Constitutional reading dispensed (39-Y 0-N) — 39–0 (pass) · upper
Sponsors
- Rodney T. Willett — primary (person)
- Irene Shin — cosponsor (person)
Timeline
The legislative action history — every referral, reading, and vote.
- 2024-01-10 Prefiled and ordered printed; offered 01/10/24 24101235D
filing, introduction - 2024-01-10 Referred to Committee on Labor and Commerce
referral-committee - 2024-01-23 Assigned L & C sub: Subcommittee #1
referral-committee - 2024-01-24 Impact statement from SCC (HB1134)
- 2024-02-06 House subcommittee amendments and substitutes offered
- 2024-02-06 Subcommittee recommends reporting with substitute (7-Y 0-N)
substitution - 2024-02-08 Reported from Labor and Commerce with substitute (22-Y 0-N)
committee-passage - 2024-02-08 Committee substitute printed 24105981D-H1
substitution - 2024-02-11 Read first time
reading-1 - 2024-02-12 Read second time
reading-2 - 2024-02-12 Committee substitute agreed to 24105981D-H1
substitution - 2024-02-12 Engrossed by House - committee substitute HB1134H1
substitution - 2024-02-13 Read third time and passed House BLOCK VOTE (99-Y 0-N)
passage, reading-3 - 2024-02-13 VOTE: Block Vote Passage (99-Y 0-N)
passage - 2024-02-14 Constitutional reading dispensed
- 2024-02-14 Referred to Committee on Commerce and Labor
referral-committee - 2024-02-16 Impact statement from SCC (HB1134H1)
- 2024-02-26 Reported from Commerce and Labor (15-Y 0-N)
committee-passage - 2024-02-28 Constitutional reading dispensed (39-Y 0-N)
- 2024-02-29 Read third time
reading-3 - 2024-02-29 Passed Senate (39-Y 0-N)
passage - 2024-03-06 Enrolled
enrolled - 2024-03-06 Bill text as passed House and Senate (HB1134ER)
passage - 2024-03-06 Signed by Speaker
passage - 2024-03-07 Signed by President
passage - 2024-03-08 Impact statement from SCC (HB1134ER)
- 2024-03-11 Enrolled Bill communicated to Governor on March 11, 2024
enrolled, executive-receipt - 2024-03-11 Governor's Action Deadline 11:59 p.m., April 8, 2024
executive-receipt - 2024-04-02 Approved by Governor-Chapter 320 (effective 7/1/24)
executive-signature - 2024-04-02 Acts of Assembly Chapter text (CHAP0320)
Source
OpenStates / OpenCivicData bulk snapshot 2026-07-01; origin ocd-bill/896d19e8-cff5-49d7-8f95-960eac7cf95b. Confidence: reported (aggregated from official Virginia legislature records).